tiprankstipranks
Trending News
More News >
Nanollose Ltd. (AU:NC6)
ASX:NC6
Australian Market

Nanollose Ltd. (NC6) AI Stock Analysis

Compare
3 Followers

Top Page

AU:NC6

Nanollose Ltd.

(Sydney:NC6)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
AU$0.06
▲(24.00% Upside)
The score is held down primarily by weak financial performance (persistent losses, zero revenue in FY2025, and ongoing cash burn). Technical indicators provide some support due to a positive trend versus key moving averages and moderately strong momentum. Valuation is also a drag given the negative P/E and lack of dividend yield.
Positive Factors
Sustainable differentiated product
Nanollose’s microbial, plant-free cellulose targets a structural shift toward sustainable materials in textiles. A fundamentally different feedstock and fermentation-based process can create durable competitive separation and long-term brand interest if scaled and certified for textile supply chains.
Clear commercialization pathway with partners
The company focuses on converting biomaterial into fibres and fabrics for downstream manufacturers and brands, supporting a B2B commercialization model. Partner-driven adoption can accelerate scale, lower capital intensity, and provide durable revenue channels if technical conversion is proven.
Low financial leverage
Reported low debt relative to assets reduces near-term solvency risk and preserves strategic optionality. With limited leverage, management can prioritize commercialization or partnerships without immediate debt refinancing pressures, which supports stability over the next several quarters.
Negative Factors
Zero revenue in FY2025
Revenue falling to zero is a major structural red flag for commercial traction; without demonstrable sales the firm cannot validate market demand or scale manufacturing. This creates sustained execution risk and makes achieving self-sustaining operations unlikely in the near term.
Persistent negative cash flow
Consistent negative operating and free cash flow means the business is dependent on external financing to fund R&D and commercialization. This ongoing cash burn constrains strategic choices, risks dilution, and creates durability risk unless cash generation improves or new funding is secured.
Ongoing losses and deteriorating margins
Sustained net losses and worsening margins hinder the company’s ability to reinvest and compound returns. Negative profitability weakens equity value, pressures cash reserves, and indicates the business model has yet to reach unit economics that would support long-term, self-funded growth.

Nanollose Ltd. (NC6) vs. iShares MSCI Australia ETF (EWA)

Nanollose Ltd. Business Overview & Revenue Model

Company DescriptionNanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre; and Jelli Grow, an alternative seed germination and plant growing material. Its products are used in textiles, nonwoven fabric, and other industries. The company was incorporated in 2014 and is based in Nedlands, Australia.
How the Company Makes MoneyNanollose Ltd. generates revenue primarily through the development and commercialization of sustainable fibers made from microbial cellulose. The company partners with textile manufacturers and fashion brands to produce and supply its eco-friendly materials. Key revenue streams include licensing its technology, selling its fibers directly to manufacturers, and potentially earning royalties from partners using its proprietary production methods. Strategic collaborations and partnerships with industry players are significant factors contributing to its earnings, as they help in scaling production and expanding market reach.

Nanollose Ltd. Financial Statement Overview

Summary
Nanollose Ltd. is facing significant financial difficulties, with declining revenues, negative profitability margins, and a weak balance sheet position. The company is struggling with cash flow management, and the negative equity raises concerns about its financial stability and sustainability.
Income Statement
12
Very Negative
Nanollose Ltd. has experienced declining revenue growth, with the latest annual report showing a significant revenue drop from the previous year. The company has negative gross and net profit margins, indicating it is currently not profitable. Additionally, EBIT and EBITDA margins are negative, reflecting operational challenges.
Balance Sheet
54
Neutral
The balance sheet indicates a negative stockholders' equity, which is concerning as it suggests the company has more liabilities than assets. The debt-to-equity ratio is not meaningful due to negative equity, and there is a lack of stability in financial position. The equity ratio is negative, indicating high financial risk.
Cash Flow
18
Very Negative
Cash flow from operations is consistently negative, and free cash flow remains in deficit, suggesting cash flow challenges. The free cash flow growth rate is not favorable, and the operating cash flow to net income ratio indicates inefficiency in converting income into cash.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.01K0.0012.50K412.16K224.61K322.86K
Gross Profit-143.09K-35.83K-779.20K58.29K-223.55K-70.57K
EBITDA-1.59M-1.59M-1.10M-1.16M-1.51M-873.73K
Net Income-1.43M-1.43M-1.16M-1.35M-1.57M-931.04K
Balance Sheet
Total Assets747.79K747.79K241.95K633.24K1.91M3.38M
Cash, Cash Equivalents and Short-Term Investments617.32K617.32K138.75K548.25K1.59M3.01M
Total Debt13.09K13.09K42.53K11.52K38.09K37.88K
Total Liabilities351.38K351.38K465.64K181.61K181.51K507.83K
Stockholders Equity396.41K396.41K-223.69K451.63K1.73M2.87M
Cash Flow
Free Cash Flow-1.10M-1.10M-900.95K-1.01M-1.39M-1.01M
Operating Cash Flow-1.10M-1.10M-900.95K-1.01M-1.38M-935.19K
Investing Cash Flow0.000.0015.97K0.00-5.35K-272.15K
Financing Cash Flow1.58M1.58M475.49K-26.57K-32.69K3.37M

Nanollose Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.05
Price Trends
50DMA
0.05
Positive
100DMA
0.05
Positive
200DMA
0.06
Positive
Market Momentum
MACD
<0.01
Negative
RSI
65.45
Neutral
STOCH
72.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NC6, the sentiment is Positive. The current price of 0.05 is below the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and below the 200-day MA of 0.06, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 65.45 is Neutral, neither overbought nor oversold. The STOCH value of 72.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NC6.

Nanollose Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
50
Neutral
AU$87.28M-9.34-49.72%10.78%
48
Neutral
AU$20.50M-9.41-1651.76%-100.00%2.86%
44
Neutral
AU$106.91M-12.94-47.98%700.00%26.88%
40
Underperform
AU$10.57M-1.79-166.70%
38
Underperform
AU$54.55M-8.00-159.86%110.44%35.90%
37
Underperform
AU$13.77M-1.61-628.72%31.87%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NC6
Nanollose Ltd.
0.06
0.05
276.47%
AU:PTX
Prescient Therapeutics Limited
0.09
0.04
93.18%
AU:ADO
AnteoTech Ltd
0.02
<0.01
11.11%
AU:CMB
Regeneus Ltd.
0.46
0.05
12.20%
AU:1AD
AdAlta Ltd.
0.01
-0.01
-50.00%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.10
-52.43%

Nanollose Ltd. Corporate Events

Nanollose Ships Upgraded Microbial Cellulose for Largest Nullarbor Pilot Spin with Birla Cellulose
Jan 4, 2026

Nanollose has delivered a 200kg upgraded batch of microbial cellulose feedstock to co-development partner Birla Cellulose’s pilot facility in India for a fourth pilot production spin of its proprietary Nullarbor fibre. Produced by China-based partner Hainan Guangyu Biotechnology using an optimised washing and treatment process, the material can now be fed directly into the lyocell process without further pre-processing, underscoring improvements in Nanollose’s international supply chain and manufacturing IP. The upcoming pilot run, expected to begin in early February and yield about 500kg of Nullarbor‑30 fibre comprising 30% microbial cellulose and 70% FSC-certified wood pulp, will be the company’s largest to date and a key technical milestone in validating Nullarbor’s compatibility with existing lyocell infrastructure. Management says the results, due in February 2026, will shape Nanollose’s 2026 development and scale-up strategy, potentially strengthening its position with commercial partners seeking sustainable fibre solutions and advancing its path toward larger-scale commercialisation.

The most recent analyst rating on (AU:NC6) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Nanollose Ltd. stock, see the AU:NC6 Stock Forecast page.

Nanollose Seeks ASX Quotation for 10 Million New Shares
Dec 22, 2025

Nanollose Limited has applied to the ASX for quotation of 10 million new ordinary fully paid shares under its issuer code NC6, with an issue date of 22 December 2025. The additional securities will increase the company’s quoted share capital, potentially affecting existing shareholders through dilution while providing Nanollose with greater flexibility to support future corporate or funding activities.

Nanollose Director Acquires Significant Options Post-AGM Approval
Dec 4, 2025

Nanollose Limited announced a change in the director’s interest, with Ms. Heidi Beatty acquiring 1,000,000 unlisted options following shareholder approval at the recent AGM. This acquisition reflects the company’s strategic moves to align its leadership’s interests with its growth objectives, potentially enhancing its market position and stakeholder confidence.

Nanollose Ltd. Issues 1 Million Unquoted Equity Securities
Dec 3, 2025

Nanollose Ltd. announced the issuance of 1,000,000 unquoted equity securities, specifically options expiring on December 3, 2028, with an exercise price of $0.066. This move is part of the company’s strategic financial activities, potentially impacting its capital structure and providing opportunities for future growth and investment in sustainable textile innovations.

Nanollose Advances Sustainable Biomaterials at 2025 AGM
Nov 7, 2025

Nanollose Limited held its 2025 Annual General Meeting, where all resolutions were determined by a poll. The company continues to advance its partnership with Birla Cellulose, having completed three successful pilot production runs of its Tree-Free Nullarbor lyocell fibre in India. These fibres have been distributed to collaborators for further testing and evaluation, indicating potential market uptake. This progress underscores Nanollose’s commitment to sustainable innovation and its strategic positioning in the biomaterials industry.

Nanollose Announces Director’s Shareholding Changes
Nov 3, 2025

Nanollose Ltd. announced a change in the director’s interest, with Mr. Winton Willesee transferring 600,000 shares through off-market transfers and 11,900,000 shares between director-related entities. This change reflects internal adjustments in shareholding, potentially impacting the company’s governance and signaling strategic shifts in stakeholder alignment.

Nanollose Achieves Milestone with Fourth Pilot Production Spin of Nullarbor-30™ Fibre
Oct 30, 2025

Nanollose Ltd. announced the successful completion of a 200kg batch of microbial cellulose by Hainan Guangyu Biotechnology, which will be shipped to Birla Cellulose’s facility in India for the fourth pilot production spin of Nullarbor-30™ fibre. This marks a significant milestone as it is the first time microbial cellulose will be directly incorporated into the lyocell process without additional pre-processing, demonstrating its compatibility with existing infrastructure. This advancement supports the scalability of Nanollose’s technology, enhancing its commercial appeal by offering a sustainable alternative to traditional pulp-based fibres.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 15, 2026